» Articles » PMID: 9362444

Developmentally-regulated Expression of Murine K-ras Isoforms

Overview
Journal Oncogene
Date 1997 Nov 15
PMID 9362444
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The products (p21) of the three mammalian H-, N- and K-ras genes play important roles in intracellular signal transduction, linking membrane receptor kinases to the nuclear pathway through raf and mitogen activated protein kinase. They are involved in the regulation of proliferation and differentiation, and activating mutations of these genes are commonly associated with human cancers. Two p21 proteins are encoded by the K-ras gene (p21K-rasA and p21K-rasB) due to alternative splicing of the last exon. While the four p21ras proteins are highly homologous, their sequences diverge significantly at the C-termini, to which distinct biochemical and perhaps even functional differences may be ascribed. However, H-, N- and K-rasB appear to be ubiquitously expressed, with little evidence of tissue-specific or developmental regulation. In contrast, we now demonstrate that the expression of K-rasA is strikingly different. K-rasA is induced during differentiation of pluripotent embryonal stem cells in vitro. Its expression during early embryogenesis is limited temporally and spatially in a tissue-specific distribution which is largely maintained as an adult. This suggests a distinct biological role for p21K-rasA.

Citing Articles

Different Ras isoforms regulate synaptic plasticity in opposite directions.

Lopez-Merino E, Fernandez-Rodrigo A, Jiang J, Gutierrez-Eisman S, Fernandez de Sevilla D, Fernandez-Medarde A EMBO J. 2025; .

PMID: 39984756 DOI: 10.1038/s44318-025-00390-8.


Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer.

Qu F, Wu S, Yu W Onco Targets Ther. 2024; 17:1223-1253.

PMID: 39735789 PMC: 11681808. DOI: 10.2147/OTT.S500281.


KRAS Inhibitors in Non-Small Cell Lung Cancer: A Review.

Tang M, Wu Y, Bai X, Lu Y Onco Targets Ther. 2024; 17:683-695.

PMID: 39206059 PMC: 11352592. DOI: 10.2147/OTT.S473368.


The role of alternative pre-mRNA splicing in cancer progression.

Choi S, Cho N, Kim E, Kim K Cancer Cell Int. 2023; 23(1):249.

PMID: 37875914 PMC: 10594706. DOI: 10.1186/s12935-023-03094-3.


Differential functions of the KRAS splice variants.

Kochen Rossi J, Nuevo-Tapioles C, Philips M Biochem Soc Trans. 2023; 51(3):1191-1199.

PMID: 37222266 PMC: 10335385. DOI: 10.1042/BST20221347.